Adage Capital Partners
CLVS

Adage Capital Partners’s Clovis Oncology, Inc. CLVS Stock Holding History

Adage Capital Partners’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,443,400
Closed -$65.5M – 776
2014
Q3 		$65.5M Buy
1,443,400
+368,400
+34% +$15.4M 0.16% 175
2014
Q2 		$44.5M Buy
1,075,000
+400,000
+59% +$20.6M 0.12% 230
2014
Q1 		$46.8M Buy
675,000
+155,635
+30% +$11.4M 0.13% 213
2013
Q4 		$31.3M Buy
+519,365
New +$28.3M 0.08% 308

Other funds holding CLVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Adage Capital Partners's CLVS Position: Q4 2014 in Review

Adage Capital Partners sold out of Clovis Oncology, Inc. (CLVS) in Q4 2014, closing a stake of 1,443,400 shares — an estimated $65.5M sold.

Adage Capital Partners first reported a position in CLVS in Q4 2013 and held it in 4 quarters. The position peaked at $65.5M in Q3 2014. 143 funds tracked by Wall St. Rank hold CLVS as of Q4 2014.

  • Adage Capital Partners reported no remaining Clovis Oncology, Inc. position as of Q4 2014 after selling out during the quarter.
  • Adage Capital Partners sold 1,443,400 Clovis Oncology, Inc. shares in Q4 2014, an estimated $65.5M.
  • Adage Capital Partners first reported a position in Clovis Oncology, Inc. in Q4 2013 and held it in 4 quarters.
  • Adage Capital Partners's Clovis Oncology, Inc. position peaked at $65.5M in Q3 2014.
  • 143 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2014.

Based on Adage Capital Partners's 13F filing for Q4 2014, filed 17 Feb 2015.